Yeo-Hyang Kim Selected Research

Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)

2/2021

PF-3845, a Fatty Acid Amide Hydrolase Inhibitor, Directly Suppresses Osteoclastogenesis through ERK and NF-κB Pathways In Vitro and Alveolar Bone Loss In Vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yeo-Hyang Kim Research Topics

Disease

1	Pericarditis 05/2022
1	COVID-19 05/2022
1	Myocarditis (Carditis) 05/2022
1	Periodontitis 02/2021
1	Alveolar Bone Loss 02/2021
1	Bone Resorption 02/2021
1	Fibrosarcoma 02/2021

Drug/Important Bio-Agent (IBA)

1	VaccinesIBA 05/2022
1	Mitogen-Activated Protein KinasesIBA 02/2021
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2021
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 02/2021
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 02/2021
1	RANK LigandIBA 02/2021
1	PF 3845IBA 02/2021

Therapy/Procedure

1	Ligation 02/2021